139 related articles for article (PubMed ID: 9570384)
1. Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma.
Piao Z; Choi Y; Park C; Lee WJ; Park JH; Kim H
Cancer Lett; 1997 Nov; 120(1):39-43. PubMed ID: 9570384
[TBL] [Abstract][Full Text] [Related]
2. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan.
Oka Y; Waterland RA; Killian JK; Nolan CM; Jang HS; Tohara K; Sakaguchi S; Yao T; Iwashita A; Yata Y; Takahara T; Sato S; Suzuki K; Masuda T; Jirtle RL
Hepatology; 2002 May; 35(5):1153-63. PubMed ID: 11981765
[TBL] [Abstract][Full Text] [Related]
3. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma.
Yang EB; Qin LL; Zhao YN; Zhang K; Chow P
Int J Mol Med; 2003 Jun; 11(6):773-8. PubMed ID: 12736721
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma.
Jang HS; Kang KM; Choi BO; Chai GY; Hong SC; Ha WS; Jirtle RL
World J Gastroenterol; 2008 Mar; 14(9):1394-8. PubMed ID: 18322954
[TBL] [Abstract][Full Text] [Related]
5. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan.
Wada I; Kanada H; Nomura K; Kato Y; Machinami R; Kitagawa T
Hepatology; 1999 Jun; 29(6):1718-21. PubMed ID: 10347113
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors.
De Souza AT; Hankins GR; Washington MK; Fine RL; Orton TC; Jirtle RL
Oncogene; 1995 May; 10(9):1725-9. PubMed ID: 7753549
[TBL] [Abstract][Full Text] [Related]
7. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.
De Souza AT; Hankins GR; Washington MK; Orton TC; Jirtle RL
Nat Genet; 1995 Dec; 11(4):447-9. PubMed ID: 7493029
[TBL] [Abstract][Full Text] [Related]
8. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors.
Mills JJ; Falls JG; De Souza AT; Jirtle RL
Oncogene; 1998 May; 16(21):2797-802. PubMed ID: 9652747
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma.
Kishimoto Y; Morisawa T; Kitano M; Shiota G; Horie Y; Suou T; Ito H; Kawasaki H; Hasegawa J
Hepatol Res; 2001 May; 20(1):68-83. PubMed ID: 11282487
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury.
Kong FM; Anscher MS; Sporn TA; Washington MK; Clough R; Barcellos-Hoff MH; Jirtle RL
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):35-41. PubMed ID: 11163495
[TBL] [Abstract][Full Text] [Related]
11. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis.
Yamada T; De Souza AT; Finkelstein S; Jirtle RL
Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10351-5. PubMed ID: 9294214
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS
Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558
[TBL] [Abstract][Full Text] [Related]
13. M6P/IGF2 receptor: a candidate breast tumor suppressor gene.
Hankins GR; De Souza AT; Bentley RC; Patel MR; Marks JR; Iglehart JD; Jirtle RL
Oncogene; 1996 May; 12(9):2003-9. PubMed ID: 8649861
[TBL] [Abstract][Full Text] [Related]
14. M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis.
Jamieson TA; Brizel DM; Killian JK; Oka Y; Jang HS; Fu X; Clough RW; Vollmer RT; Anscher MS; Jirtle RL
BMC Cancer; 2003 Feb; 3():4. PubMed ID: 12589712
[TBL] [Abstract][Full Text] [Related]
15. M6P/IGF2R is mutated in squamous cell carcinoma of the lung.
Kong FM; Anscher MS; Washington MK; Killian JK; Jirtle RL
Oncogene; 2000 Mar; 19(12):1572-8. PubMed ID: 10734317
[TBL] [Abstract][Full Text] [Related]
16. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene.
Oates AJ; Schumaker LM; Jenkins SB; Pearce AA; DaCosta SA; Arun B; Ellis MJ
Breast Cancer Res Treat; 1998 Feb; 47(3):269-81. PubMed ID: 9516081
[TBL] [Abstract][Full Text] [Related]
17. Mannose 6-phosphate/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate?
DaCosta SA; Schumaker LM; Ellis MJ
J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):85-94. PubMed ID: 10791771
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the gene encoding the human mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in human cell lines resistant to growth inhibition by transforming growth factor beta(1) (TGF-beta(1)).
Gemma A; Hosoya Y; Uematsu K; Seike M; Kurimoto F; Yoshimura A; Shibuya M; Kudoh S
Lung Cancer; 2000 Nov; 30(2):91-8. PubMed ID: 11086202
[TBL] [Abstract][Full Text] [Related]
19. Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma.
Piao Z; Park C; Lee JS; Yang CH; Choi KY; Kim H
Cancer Lett; 1998 Jan; 122(1-2):201-7. PubMed ID: 9464511
[TBL] [Abstract][Full Text] [Related]
20. High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer.
Huang Z; Wen Y; Shandilya R; Marks JR; Berchuck A; Murphy SK
Nucleic Acids Res; 2006; 34(2):555-63. PubMed ID: 16432260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
